ORI
Oak Ridge Investments Portfolio holdings
AUM
$1.39B
1-Year Return
33.33%
This Quarter Return
+33.86%
1 Year Return
+33.33%
3 Year Return
+165.84%
5 Year Return
+254.68%
10 Year Return
+830.04%
AUM
$1.19B
AUM Growth
+$215M
(+22%)
Cap. Flow
-$74.5M
Cap. Flow
% of AUM
-6.25%
Top 10 Holdings %
Top 10 Hldgs %
27.36%
Holding
191
New
25
Increased
19
Reduced
127
Closed
18
Top Buys
| 1 |
COR
Coresite Realty Corporation
COR
|
$8.31M |
| 2 |
Repay Holdings
RPAY
|
$6.58M |
| 3 |
Cerence
CRNC
|
$5.35M |
| 4 |
Palomar
PLMR
|
$4.93M |
| 5 |
Kinsale Capital Group
KNSL
|
$4.42M |
Top Sells
| 1 |
ADSW
Advanced Disposal Services, Inc.
ADSW
|
$12.2M |
| 2 |
FIVE9
FIVN
|
$9.85M |
| 3 |
Yeti Holdings
YETI
|
$7.86M |
| 4 |
Pool Corp
POOL
|
$7.34M |
| 5 |
Omnicell
OMCL
|
$5.63M |
Sector Composition
| 1 | Technology | 31.08% |
| 2 | Healthcare | 18.21% |
| 3 | Industrials | 11.03% |
| 4 | Consumer Discretionary | 9.6% |
| 5 | Communication Services | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Intuit
INTU
$186B
| $6M | 0.5% |
20,238
-2
| -0% | -$592 |
|
77
Abbott
ABT
$231B
| $5.74M | 0.48% |
62,763
-657
| -1% | -$60.1K |
|
78
KLA
KLAC
$115B
| $5.61M | 0.47% |
28,851
-388
| -1% | -$75.5K |
|
|
79
Cerence
CRNC
$433M
| $5.35M | 0.45% |
+131,097
| New | +$5.35M |
|
80
Heron Therapeutics
HRTX
$202M
| $5.31M | 0.45% |
361,141
-24,588
| -6% | -$362K |
|
81
Enovis
ENOV
$1.8B
| $5.27M | 0.44% |
109,637
-39,024
| -26% | -$1.87M |
|
82
Unilever
UL
$159B
| $5.25M | 0.44% |
95,744
-151
| -0.2% | -$8.29K |
|
83
Arrowhead Research
ARWR
$3.87B
| $5.09M | 0.43% |
117,952
-13,550
| -10% | -$585K |
|
|
84
Palomar
PLMR
$3.38B
| $4.93M | 0.41% |
+57,462
| New | +$4.93M |
|
85
Five Below
FIVE
$8.43B
| $4.86M | 0.41% |
45,444
-33,729
| -43% | -$3.61M |
|
|
ALXN
86
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $4.75M | 0.4% |
42,311
-177
| -0.4% | -$19.9K |
|
87
argenx
ARGX
$44.9B
| $4.7M | 0.39% |
20,884
-11,529
| -36% | -$2.6M |
|
88
Charter Communications
CHTR
$35.4B
| $4.48M | 0.38% |
8,787
+53
| +0.6% | +$27K |
|
|
89
Kinsale Capital Group
KNSL
$10.7B
| $4.42M | 0.37% |
+28,453
| New | +$4.42M |
|
|
XLRN
90
DELISTED
Acceleron Pharma Inc.
XLRN
| $4.41M | 0.37% |
46,273
-3,537
| -7% | -$337K |
|
91
LKQ Corp
LKQ
$8.31B
| $4.29M | 0.36% |
163,854
-17,098
| -9% | -$448K |
|
92
Sarepta Therapeutics
SRPT
$1.93B
| $4.25M | 0.36% |
26,483
-2,597
| -9% | -$416K |
|
93
Mesa Laboratories
MLAB
$354M
| $4.07M | 0.34% |
+18,753
| New | +$4.07M |
|
94
Marsh & McLennan
MMC
$101B
| $3.99M | 0.33% |
37,165
-790
| -2% | -$84.8K |
|
95
Vicor
VICR
$2.33B
| $3.66M | 0.31% |
+50,871
| New | +$3.66M |
|
96
Edwards Lifesciences
EW
$47.5B
| $3.52M | 0.3% |
50,937
-1,632
| -3% | -$113K |
|
97
Insmed
INSM
$30.1B
| $3.49M | 0.29% |
+126,682
| New | +$3.49M |
|
|
ATVI
98
DELISTED
Activision Blizzard Inc.
ATVI
| $3.38M | 0.28% |
44,472
+18
| +0% | +$1.37K |
|
99
Travere Therapeutics
TVTX
$1.89B
| $3.34M | 0.28% |
163,804
-18,313
| -10% | -$374K |
|
100
OrthoPediatrics
KIDS
$519M
| $3.34M | 0.28% |
76,224
-6,281
| -8% | -$275K |
|